Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1981-9-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0312-5963
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
275-97
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6166422-Animals,
pubmed-meshheading:6166422-Antithyroid Agents,
pubmed-meshheading:6166422-Cardiac Glycosides,
pubmed-meshheading:6166422-Humans,
pubmed-meshheading:6166422-Hyperthyroidism,
pubmed-meshheading:6166422-Hypothyroidism,
pubmed-meshheading:6166422-Kinetics,
pubmed-meshheading:6166422-Liver,
pubmed-meshheading:6166422-Pharmaceutical Preparations
|
pubmed:articleTitle |
Influence of thyroid dysfunction on drug pharmacokinetics.
|
pubmed:publicationType |
Journal Article,
Review
|